Ryan Renee — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Ryan Renee has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Ryan Renee is identified in SEC filings as a Director of NeuroPace, Inc. as of the filing date 2026-06-05. NeuroPace is a medical device company focused on neuromodulation therapies for epilepsy. Public information beyond the SEC filing is limited, and there is no readily verifiable biographical detail available about Renee's education or prior roles from the provided context.

Board memberships

• NeuroPace Inc

Awards & honors

• Named as Director of NeuroPace, Inc. per SEC filing dated 2026-06-05.

Recent Transactions

Companies — Last 90 Days

• NeuroPace Inc (NPCE) — 1 filings, last 2026-06-05

Frequently Asked Questions

Who is Ryan Renee?

Ryan Renee is identified in SEC filings as a Director of NeuroPace, Inc. as of the filing date 2026-06-05. NeuroPace is a medical device company focused on neuromodulation therapies for epilepsy. Public information beyond the SEC filing is limited, and there is no readily verifiable biographical detail available about Renee's education or prior roles from the provided context.…

How many SEC Form 4 filings has Ryan Renee submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Ryan Renee's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week